MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$2,352K
Restricted cash
$23K
Cash and cash
equivalents
$6K
Capitalized software, net
$96K
Operating lease
right-of-use asset, net
$341K
Property and equipment,
net
$13,024K
Total current assets
$2,381K
Total assets
$15,842K
Accumulated deficit
-$191,066K
Subscription receivable
$182K
Total liabilities and
stockholders deficit
$15,842K
Total stockholders
deficit
-$50,332K
Additional paid-in capital
$140,911K
Common stock, 0.0001
par value...
$5K
Total liabilities
$66,174K
Deferred tax liabilities
$8K
Operating lease
liability, non-current
$206K
Senior convertible
promissory notes, due to...
$11,077K
Derivative warrant
liabilities
$10,995K
Total current
liabilities
$43,888K
Other current
liabilities
$65K
Convertible debt-Bridge
Loan
$196K
Operating lease
liability, current
$154K
Revolving line of credit
$4,257K
Related party loans
$4,000K
Convertible
debt-Promissory Notes
$18,303K
Forward purchase
derivative liabilities
$175K
Accounts payable and
accrued expenses
$16,738K
Back
Back
Balance Sheet
source: myfinsight.com
NKGen Biotech, Inc. (NKGN)
NKGen Biotech, Inc. (NKGN)